TxSUS Sessions

TxSUS Sessions are live webinars with expert speakers discussing key issues at the intersection of policy and practice. The goal of these sessions is to promote awareness, engagement, and support for innovative projects addressing substance use in Texas.

For additional learning opportunities, visit the Center for Substance Use Training and Telementoring (C-STAT). C-STAT provides free, evidence-based training to an array of healthcare professionals on best practices for responding to substance use. Access ongoing mentoring through their Project ECHO series or request technical assistance to learn more.

The Texas Opioid Training Initiative offers a compendium of free online continuing education programs and other clinical resources for health professionals.

Upcoming TxSUS Sessions:

Coming Soon

Navigating Recovery in Rural Texas: Innovative Perspectives on MOUD Delivery

Thursday, May 30 @ 12 – 1 p.m. CST

Learning Objectives:

  • Describe the need for medications for substance use disorders in rural substance use treatment services.
  • Compare and contrast three models for medication for opioid use disorder (MOUD) treatment services.
  • Explain lessons learned from an office-based opioid treatment program (OBOT), opioid treatment program (OTP), and fully remote telehealth MOUD program in rural Texas communities.

May Speakers:

Fernando Lozano pic

Fernando Lozano, LCDC, PSS
Clinical Manager
The Association for the Advancement of
Mexican Americans (AAMA)

Jake Mumm

Jake Mumm, MD
Medical Director
Olive Branch Recovery

Ralf Lukner Headshot

Ralf Lukner, MD, PhD
Founder and Primary Care Physician
Lukner Medical Clinic

1 CEU will be awarded for CPE, CME, CNE and SWs.

Navigating Recovery in Rural Texas: Innovative Perspectives on MOUD Delivery

Thursday, May 30 @ 12 – 1 p.m. CST

Learning Objectives:

  • Describe the need for medications for substance use disorders in rural substance use treatment services.
  • Compare and contrast three models for medications for opioid use disorders (MOUD) treatment services.
  • Explain lessons learned from an office-based opioid treatment program (OBOT), opioid treatment program (OTP), and fully remote telehealth MOUD program in rural Texas communities.

May Speakers:

May Speakers:

Jeffrey Bratberg

Jeffrey Bratberg, PharmD, FAPhA
Clinical Professor
College of Pharmacy
University of Rhode Island

1 CEU will be awarded for CPE, CME, CNE and SWs.

Past Sessions:

2024 Texas Substance Use Symposium

February 29 – March 1, 2024

The following keynote sessions were recorded at TxSUS 2024 in Austin, Texas:

  • System Transformation to Address the Overdose Crisis – Chethan Bachireddy, MD
  • Drug Policy Myths & A Roadmap for Change – Regina LaBelle, JD
  • We Are the Medicine – Sam Rivera

Explore all the sessions from TxSUS 2024 by clicking the button below.

Audience at TxSUS 2024 in Austin, TX

Pharmacy-Based Buprenorphine Induction:
A Care Model for the Underserved

November 15, 2023

Jeffrey Bratberg, PharmD, FAPhA
Clinical Professor
College of Pharmacy
University of Rhode Island

Fentanyl: Fuel on the Policy Fire
Balancing Public Health and Criminal Justice Responses to SUD

August 31, 2023

Morgan Godvin
Research Associate
Action Lab – Center for Health Policy & Law
Northeastern University

2023 Texas Substance Use Symposium

March 27-28, 2023

The following sessions were recorded at TxSUS 2023 in San Antonio Texas:

  • Buprenorphine Induction Strategies in the Age of Fentanyl – Dr. Tirado
  • The Other MAT: Medications for Alcohol and Stimulant Use Disorders – Dr. Wakhlu
  • Treatment for Substance Use Disorders in Youth – Dr. Ramamurthy
  • Stigma Kills – Addressing Opioid and Substance Use Disorder by Changing Health System Culture – Dr. Bottner

Claim home study CE credit for viewing any of the above recorded sessions

2023 CDC Guideline for Prescribing Opioids for Pain

February 15, 2022

Stefan Kertesz, MD
Professor,
The University of Alabama Marnix E. Heersink School of Medicine

Opportunities & Challenges in Telehealth for Substance Use Disorder

December 9, 2022

Carlos F. Tirado, MD, MPH, FASAM
Chief Medical Officer,
CARMAHealth

Lesley Mason, PsyD
Clinical Associate Professor,
Arizona State University

Jennifer Sharpe Potter, PhD, MPH
Executive Director,
Be Well Texas

Exploring Sustainable Funding Models for Substance Use Disorder Treatment and Recovery

July 20, 2022

Karla Ramirez, LCSW, MSSW, MSHA
Director, Be Well Texas
UT Health San Antonio

The Real & Imagined Risks of Novel Synthetic Drugs

February 8, 2022

Claire M. Zagorski, MSc, LP
Program Coordinator, PhARM
College of Pharmacy
The University of Texas at Austin

Lucas G. Hill, PharmD, BCACP
Director, The University of Texas at Austin PhARM Program

The Technology Dilemma: Can Technology Fix the Overdose Crisis?

December 1, 2021

Kasey Claborn, PhD
Assistant Professor
The University of Texas
at Austin
Steve Hicks School of
Social Work

Daniela Luzi Tudor
Co-Founder and CEO,
WEconnect

Claire M. Zagorski, MSc, LP
Program Coordinator, PhARM
College of Pharmacy
The University of Texas at Austin

Mobile Methadone: Policy Implications and Notes from the Field

September 29, 2021

Corey Davis, JD, MSPH, EMT
Director, Harm Reduction Legal Project,
Deputy Director, Southeastern Region

Sean Soth
Director of Health and Integration
Evergreen Treatment Services

Catherine Perez
Director of Strategic Initiatives
Evergreen Treatment Services

Secured By miniOrange